W-SCOPE Corporation FY2027 Q1 Earnings Report

Quick View

Executive Summary

While revenue recovered significantly, increasing 83.2% year on year, the Company continued to post a net loss due to the burden of non-operating expenses, primarily the equity-method investment loss. The most important point for the current period is that the benefits of higher revenue have not flowed through to net income. Revenue was ¥1.39B (¥0.76B in the same period last year, +83.2%), while operating income was ¥-0.36B (¥-1.49B in the same period last year, +75.6%), representing a narrowing of the loss. Ordinary income and net income were both ¥-2.03B (¥-2.84B and ¥-2.85B in the same period last year, respectively, both +28.6%), indicating that the improvement in final earnings has lagged the improvement at the operating level. The primary drivers were higher revenue and improved profitability in the Ion-Exchange Membrane Business, but the continued loss in the Separator Business and the ¥1.68B equity-method investment loss remained significant burdens below the operating level.

Factors Affecting Business Performance

【Revenue】Revenue was ¥1.39B, up +83.2% year on year, with both businesses posting higher revenue. The Ion-Exchange Membrane Business grew to ¥0.80B (+193.0% year on year), accounting for 57.5% of total revenue and becoming the Company’s core business, while the Separator Business also recovered to ¥0.59B (+21.7% year on year). The primary driver of revenue growth was expanding demand for the Ion-Exchange Membrane Business, which accounted for the majority of the increase in revenue.

【Profit and Loss】Operating income was ¥-0.36B (¥-1.49B in the same period last year), representing a narrowing of the loss, while the operating margin improved substantially to -26.3% (-197.6% in the same period last year). By segment, the Ion-Exchange Membrane Business generated profit of ¥0.52B (profit margin of 65.1%) and became the earnings pillar, while the Separator Business continued to post a loss of ¥-0.65B. Ordinary income remained at ¥-2.03B (¥-2.84B in the same period last year, +28.6%), with the ¥1.68B equity-method investment loss accounting for the majority of non-operating expenses of ¥1.76B and serving as the primary cause of the larger ordinary loss. Net income was also ¥-2.03B, broadly in line with ordinary income, while the tax burden was minor at ¥0.01B in income taxes and other taxes. Although business earnings improved as a result of higher revenue, the improvement in final earnings was limited by the equity-method loss. In conclusion, this was not a case of higher revenue and lower profit, but rather higher revenue and a narrowing loss.

Segment Analysis

The Separator Business generated revenue of ¥0.59B (+21.7% year on year) and a segment loss of ¥0.65B (an improvement of +50.6% from the ¥-0.65B range in the same period last year), and remains the largest profitability-related challenge. The Ion-Exchange Membrane Business showed a substantial improvement in profitability, with revenue of ¥0.80B (+193.0% year on year) and segment profit of ¥0.52B (profit margin of 65.1%, +750.8% year on year), making it the primary driver of the improvement in consolidated earnings. The profitability gap between the two businesses is extremely large, resulting in a structure in which consolidated earnings depend on the earnings power of the Ion-Exchange Membrane Business.

Key Financial Indicators

【Profitability】The operating margin improved substantially to -26.3% (-197.6% in the same period last year), but the gross margin remained negative at -9.0% (-164.4% in the same period last year), indicating that losses remain at the manufacturing stage. The net profit margin was extremely low at -146.7%, strongly affected by the equity-method investment loss.【Cash Flow Quality】Cash and deposits increased to ¥0.78B from ¥0.27B in the same period last year, but remain small relative to current liabilities of ¥6.52B, leaving limited financial flexibility. 【Investment Efficiency】ROE was -5.1% (based on Q1 alone), and the valuation and earnings contribution of investment securities of ¥33.74B, which account for 67.4% of total assets, have a significant impact on capital efficiency. 【Financial Soundness】The equity ratio remained high at 80.1% (78.5% in the same period last year), but current liabilities of ¥6.52B exceeded current assets of ¥3.53B, resulting in a current ratio below 100% and a high degree of reliance on short-term borrowings of ¥5.34B.

Cash Flow Analysis

Although detailed disclosure of the cash flow statement is unavailable, changes in the balance sheet provide some insight into the Company’s cash position. Cash and deposits increased to ¥0.78B from ¥0.27B in the same period last year, while short-term borrowings decreased to ¥5.34B (¥6.67B in the same period last year) and long-term borrowings increased to ¥2.17B (¥1.18B in the same period last year), suggesting that the Company may have revised its funding structure from short-term to long-term financing. Despite continuing operating losses, investment securities remained at approximately ¥33.46B, compared with ¥33.74B (in the same period last year), indicating that no large-scale asset sales were conducted. Overall, the Company appears to have increased cash on hand by adjusting the composition of its borrowings during the current period.

Quality of Earnings

There was virtually no difference between ordinary income and final earnings, with only ¥0.01B in income taxes and other taxes, indicating limited distortion in earnings quality from the tax burden. However, the primary cause of the larger ordinary loss was the non-cash accounting loss of ¥1.68B from equity-method investments, whose impact was also substantial compared with the ¥0.06B foreign exchange gain included in non-operating income. At the operating level, qualitative improvement was evident due to higher revenue and improved absorption of costs, but earnings below the ordinary income level remain heavily dependent on the performance of equity-method investees. Consequently, earnings quality remains fragile, as the effective driver of consolidated earnings volatility lies in the valuation of non-operating investments. Comprehensive income was ¥-1.30B, a smaller loss than net income of ¥-2.03B, with the ¥0.23B foreign currency translation adjustment and the ¥0.50B share of OCI of equity-method investees contributing positively.

Earnings Forecast and Guidance

Against the full-year revenue forecast of ¥6.00B, Q1 progress was 23.1%, slightly below the standard 25%. Against the full-year operating loss forecast of ¥-2.40B, the Q1 operating loss of ¥-0.36B represented progress of only 15.2%, suggesting that the operating earnings forecast incorporates a plan for improvement toward the second half of the fiscal year. Meanwhile, against the full-year ordinary loss forecast of ¥-4.40B, the Q1 ordinary loss of ¥-2.03B represented progress of 46.2%, indicating that achievement of the full-year plan will depend heavily on trends in non-operating factors, including equity-method investment income and losses. There were no revisions to either the earnings forecast or the dividend forecast.

Shareholder Returns

The dividend forecast for both the current period and the full-year forecast is ¥0 per share, indicating a policy of continuing to pay no dividends. As net losses continue, discussion of the payout ratio is not applicable, and no shareholder returns are currently being made.

Risk Factors

1. Prolonged low profitability in the Separator Business: The Separator Business posted a segment loss of ¥0.65B against revenue of ¥0.59B. If improvements in capacity utilization, yield, and fixed-cost absorption are delayed, it will continue to burden consolidated earnings.

2. Impact of the equity-method investment loss on consolidated earnings: The ¥1.68B equity-method investment loss accounts for the majority of the ¥2.03B ordinary loss, creating a structure in which the performance and valuation of investees significantly affect consolidated final earnings.

3. Reliance on short-term funding: Short-term borrowings of ¥5.34B account for 82.0% of current liabilities of ¥6.52B, and the current ratio is below 100%. Refinancing conditions and relationships with financial institutions are directly linked to the stability of the Company’s cash management.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Company’s operating margin and net profit margin are substantially below the industry median, placing the Company toward the lower end of the industry in terms of profitability.

Growth and Capital Efficiency

The revenue growth rate is substantially above the industry median, placing the Company toward the upper end of the industry in terms of revenue growth momentum.

※Source: Compiled by the Company

Key Points in the Financial Results

1. Revenue increased 83.2% year on year, while the operating loss narrowed 75.6% year on year, making the progress in business-level earnings improvement a key point in the results. However, reliance on the Ion-Exchange Membrane Business for earnings has increased.

2. The Separator Business’s segment loss of ¥0.65B and consolidated gross margin of -9.0% remain structural constraints on achieving profitability at the operating level.

3. Due to the ¥1.68B equity-method investment loss, the improvement in operating earnings has not sufficiently flowed through to final earnings. Going forward, the performance trends of investees and liquidity (cash/short-term borrowings ratio) will be important points to monitor in understanding the earnings structure.

Theoretical Share Price (Reference Value)

Sensitivity: ¥322–¥339 at cost of equity ±1%, and ¥322–¥336 at ω±0.1.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value will be below book value per share.
• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 showed a substantial operating recovery for Double Scope, but profitability remains negative and the quarter was dominated by a large equity-method loss. Revenue increased 83.2% YoY to ¥1.386bn. The separator business generated revenue of ¥589mn, up 21.7% YoY, while the ion-exchange membrane business rose 193.0% YoY to ¥797mn. The ion-exchange membrane business was the core business by segment profit contribution, generating ¥519mn of segment profit. In contrast, the separator business reported a ¥645mn segment loss, although this narrowed sharply from a ¥1.305bn loss a year earlier. Consolidated gross loss narrowed dramatically to ¥125mn from ¥1.243bn. Accordingly, the gross margin improved to -9.0% from -164.4%, an expansion of approximately 15,540bp. Operating loss narrowed to ¥364mn from ¥1.494bn. The operating margin improved to -26.3% from -197.6%, an expansion of approximately 17,130bp, reflecting much better utilization of the expanded revenue base and reduced SG&A. SG&A declined 4.8% YoY to ¥238mn despite the sharp sales increase, indicating meaningful operating leverage. However, ordinary loss remained substantial at ¥2.028bn because non-operating expenses totaled ¥1.761bn. Equity in losses of affiliates accounted for ¥1.682bn of that expense, making affiliate performance the principal reason that the net loss remained ¥2.033bn. Net margin was consequently -146.7%, materially weaker than the operating margin and illustrating that below-the-line investment exposure, rather than the consolidated manufacturing operations alone, is driving the loss. Net loss nevertheless improved 28.6% YoY from ¥2.848bn, and loss per share narrowed to ¥33.93 from ¥51.87. Management maintained its full-year outlook for ¥6.0bn of sales, a ¥2.4bn operating loss, and a ¥4.4bn net loss, with no forecast or dividend revision. Q1 sales represent 23.1% of the full-year sales plan, close to the standard 25% first-quarter pace. The operating loss represents 15.2% of the full-year planned loss, suggesting a less loss-heavy operating profile than the annual guidance assumes. Conversely, the Q1 net loss already represents 46.2% of the full-year forecast loss because of the affiliate loss, so recovery in investee profitability is essential to achieving the full-year target. The balance sheet has high equity backing, but immediate liquidity is tight because short-term borrowings significantly exceed cash and current assets. The near-term investment case is therefore centered on sustained gross-margin normalization in separators, continued profitability in ion-exchange membranes, and containment of equity-method losses.

Profitability Analysis

The annualized DuPont ROE is -20.3%, comprising a -146.7% net profit margin, 0.111x annualized asset turnover, and 1.25x financial leverage. The negative net margin is the decisive drag on returns, while leverage is modest and does not indicate balance-sheet overextension. Annualized asset turnover is low, consistent with the asset-intensive production and investment base relative to current sales. The largest YoY improvement occurred in operating profitability: gross margin improved by approximately 15,540bp and operating margin by approximately 17,130bp. Revenue growth of 83.2% materially exceeded SG&A growth, with SG&A declining 4.8%, demonstrating strong operating leverage from the higher sales base. The ion-exchange membrane segment produced a 65.1% segment margin, versus a -109.5% segment margin in separators. This mix explains the sharp consolidated gross-loss reduction, although the separator segment remains loss-making and continues to prevent consolidated gross profitability. EBIT margin was -26.3%, and annualized ROIC was -3.1%, both indicating that the current operating base is not yet earning an adequate return on deployed capital. Interest coverage was -5.06x because EBIT remained negative; the ratio is a warning sign for debt service capacity even though interest expense itself was only ¥72mn. The five-factor DuPont interest burden of 5.571x is not economically meaningful in the normal sense because EBIT and earnings before tax were both negative and non-operating losses exceeded the operating loss. The effective tax rate was -0.2%, reflecting the loss position and a ¥5mn tax expense. Under JGAAP, there was no reported goodwill amortization effect in the available results, and intangible assets were immaterial at 0.0% of assets.

Growth Assessment

Revenue growth was broad-based, with both reported segments expanding, but the growth composition shifted strongly toward the profitable ion-exchange membrane operation. Separator revenue increased ¥105mn YoY, while ion-exchange membrane revenue increased ¥525mn YoY and accounted for 76.2% of consolidated Q1 revenue. The separator segment's loss narrowed by ¥660mn YoY, showing that the revenue recovery is improving fixed-cost absorption, but the segment has not yet crossed into profitability. The ion-exchange membrane segment improved from ¥61mn of profit to ¥519mn, a ¥458mn increase, and was the principal contributor to the improvement in consolidated gross profit. Consolidated operating loss narrowed by ¥1.130bn YoY, a larger improvement than the ¥630mn increase in revenue, confirming favorable operating leverage. The full-year sales forecast implies 65.2% YoY growth, so Q1's 83.2% pace is ahead of the annual growth assumption. Q1 sales progress of 23.1% is only 1.9 percentage points below the standard 25% first-quarter run rate and does not by itself suggest a material shortfall. The full-year operating-loss forecast of ¥2.4bn implies further improvement is required after the Q1 operating loss of ¥364mn, but the Q1 loss is below a straight-line quarterly loss profile. The full-year net-loss forecast of ¥4.4bn requires a marked reduction in losses below operating income after Q1's ¥2.033bn net loss. Foreign-exchange gains of ¥62mn provided limited support, equivalent to 4.5% of revenue, but did not offset the affiliate loss. Sustained growth quality depends on separators reaching positive gross profitability and on the ion-exchange membrane segment maintaining its unusually high current segment margin.

Financial Health

Liquidity is the principal financial risk. The current ratio was 54.2% and the quick ratio was 43.3%, both well below 1.0x; this indicates that current assets are insufficient to cover current liabilities. Working capital was negative ¥2.986bn. Current assets were ¥3.531bn against current liabilities of ¥6.517bn, while short-term loans alone were ¥5.344bn. Cash and deposits of ¥778mn covered only 0.15x of short-term debt, which is a severe liquidity-stress indicator. Short-term debt represented 71.1% of interest-bearing debt, creating a clear refinancing requirement and a maturity mismatch between near-term funding obligations and liquid assets. Long-term loans increased ¥991mn YoY, or 83.8%, to ¥2.173bn, while short-term loans fell ¥1.327bn; this indicates some extension of debt maturity but does not eliminate the large short-term funding burden. Cash increased ¥507mn YoY, or 187.1%, but remains modest relative to ¥5.344bn of short-term loans. Total interest-bearing debt was ¥7.517bn, equal to a conservative 0.25x debt-to-equity ratio and 15.8% debt-to-capital. Total equity of ¥40.076bn represented 80.1% of total assets, providing substantial accounting loss-absorption capacity. However, the quality and liquidity of the asset base matter: investment securities were ¥33.740bn, or 67.4% of total assets, whereas cash was only 1.6% of assets. Deferred tax assets were ¥1.324bn, equivalent to 3.3% of equity, and their recoverability depends on a return to taxable profitability. Asset retirement obligations were ¥762mn, or 7.7% of total liabilities, above the 5% warning benchmark and material for a manufacturing company with facility-related restoration obligations. Construction in progress was ¥2.503bn, equal to 22.5% of PPE, indicating a sizeable investment pipeline that requires disciplined completion and ramp-up to avoid further pressure on returns. There was no reported segment impairment in Q1, but the high level of investment securities and continuing affiliate losses heighten the importance of preserving investment values.

Notable B/S Changes

Cash and deposits: +¥507mn (+187.1%) to ¥778mn — cash improved materially YoY, but remains only 0.15x of ¥5.344bn short-term loans and does not resolve liquidity pressure. Long-term loans: +¥991mn (+83.8%) to ¥2.173bn — indicates partial debt-maturity extension, although short-term loans still account for 71.1% of interest-bearing debt. Construction in progress: -¥709mn (-22.1%) to ¥2.503bn — investment projects remain material at 22.5% of PPE; conversion into operating assets and productive capacity remains important. Total equity: -¥857mn (-2.1%) to ¥40.076bn — the Q1 net loss was partly offset by positive other comprehensive income, preserving a high 80.1% equity-to-assets ratio.

Cash Flow Quality

Dividend Sustainability

The full-year dividend forecast is ¥0 per share, and management has not revised this policy. With a Q1 net loss of ¥2.033bn, negative retained earnings of ¥30.192bn, and a full-year net-loss forecast of ¥4.4bn, there is no basis for a dividend payout. Retaining capital is appropriate given the current ratio of 54.2%, cash coverage of short-term debt of 0.15x, and the need to manage refinancing and ongoing production investment. No share buyback was indicated; therefore, no total return ratio is applicable. Near-term capital-allocation priorities are balance-sheet liquidity, repayment or refinancing of short-term debt, and restoration of operating profitability.

Risk Assessment

Business risks include Separator business profitability: the segment remained loss-making at ¥645mn despite 21.7% revenue growth, leaving consolidated gross margin negative at -9.0%., Affiliate performance risk: equity in losses of affiliates was ¥1.682bn, equivalent to 82.7% of the Q1 net loss and the main source of the large divergence between operating loss and net loss., Demand, pricing, and utilization risk in battery-material manufacturing: the separator operation requires further volume and/or pricing improvement to absorb fixed production costs and achieve positive gross profit., Investment execution risk: construction in progress of ¥2.503bn, 22.5% of PPE, requires timely completion, customer qualification, and ramp-up to generate acceptable returns., Foreign-exchange exposure: Q1 included ¥62mn of FX gains; future exchange-rate movements can affect reported earnings and the economics of overseas operations..

Financial risks include Low liquidity: current ratio of 0.54x and quick ratio of 0.43x are below 1.0x, leaving current assets insufficient to cover current liabilities., Refinancing risk: ¥5.344bn of short-term loans comprise 71.1% of interest-bearing debt, and cash covers only 0.15x of that short-term debt., Debt-service risk: interest coverage was -5.06x because EBIT was negative, meaning operating earnings do not currently cover financing costs., Environmental and site-restoration obligation risk: asset retirement obligations of ¥762mn equal 7.7% of liabilities, above the 5% warning threshold., Investment-asset valuation risk: investment securities represent 67.4% of total assets, and continued equity-method losses could pressure earnings and asset values..

Key concerns include Highest priority: restoring liquidity headroom through refinancing, debt maturity management, and preservation of cash., Highest priority: reversing the ¥1.682bn equity-method loss, without which operating recovery will not translate into net-profit recovery., High priority: converting separator revenue growth into positive gross profit; the -109.5% segment margin remains unsustainable., High priority: ensuring construction-in-progress assets begin contributing to utilization and returns rather than increasing idle-capital exposure., Moderate priority: preserving the profitability and growth of ion-exchange membranes, which currently supplies all positive segment profit..

Investment Implications

Key takeaways include Q1 operating performance improved sharply: revenue rose 83.2%, gross loss narrowed by ¥1.118bn, and operating loss narrowed by ¥1.130bn YoY., Ion-exchange membranes generated ¥519mn of segment profit and are the core earnings contributor, while separators remain the operating turnaround requirement., The ¥1.682bn equity-method loss overwhelmed the operating recovery and caused a ¥2.033bn net loss., The company has high equity capitalization and low D/E of 0.25x, but its liquidity profile is strained by a 0.54x current ratio and ¥5.344bn of short-term loans., Q1 sales tracked close to the full-year plan, but full-year net-loss guidance depends on a significant reduction in below-the-line investment losses..

Metrics to watch include Separator segment revenue, segment profit, and gross-margin trajectory, Ion-exchange membrane segment margin sustainability, Equity-method income or loss and the carrying value of investment securities, Cash balance, short-term loans, refinancing actions, current ratio, and cash-to-short-term-debt coverage, Construction-in-progress completion and subsequent utilization, Progress against the full-year ¥6.0bn sales, ¥2.4bn operating-loss, and ¥4.4bn net-loss forecasts.

Regarding relative positioning, The company combines a potentially high-growth battery-material manufacturing exposure with a currently weak liquidity and operating-return profile. Its equity capitalization is stronger than the short-term liquidity ratios imply, but compared with a financially mature manufacturer it remains disadvantaged by negative gross margin, negative ROIC, inadequate interest coverage, concentrated short-term funding, and material dependence on affiliate performance.